Skip to main content

Table 4 Sensitivity analysis

From: Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation

 

ADMA

SDMA

ADMA:SDMA

Inflammation

Normal

High

Normal

High

Normal

High

Ach%

0.067 (p = 0.397)

0.251 (p = 0.216)

−0.077 (p = 0.325)

−0.401 ( p  = 0.042)

0.128 (p = 0.108)

0.406 ( p  = 0.040)

SNP%

0.016 (p = 0.840)

0.173 (p = 0.397)

−0.018 (p = 0.816)

−0.404 ( p  = 0.040)

0.023 (p = 0.776)

0.384 (p = 0.053)

FMD%

−0.002 (p = 0.976)

0.185 (p = 0.365)

0.099 (p = 0.220)

−0.165 (p = 0.421)

−0.076 (p = 0.353)

0.280 (p = 0.165)

GTN%

−0.023 (p = 0.782)

−0.090 (p = 0.698)

−0.052 (p = 0.540)

0.007 (p = 0.978)

0.033 (p = 0.698)

−0.090 (p = 0.697)

cIMT

0.100 (p = 0.247)

−0.482 ( p  = 0.017)

0.005 (p = 0.958)

−0.231 (p = 0.278)

0.064 (p = 0.466)

−0.101 (p = 0.637)

SEVR

−0.013 (p = 0.869)

0.039 (p = 0.865)

0.124 (p = 0.121)

0.255 (p = 0.251)

−0.091 (p = 0.264)

−0.303 (p = 0.170)

AIx (HR75)

−0.011 (p = 0.893)

0.272 (p = 0.222)

0.069 (p = 0.398)

−0.287 (p = 0.195)

−0.065 (p = 0.434)

0.527 ( p  = 0.012)

  1. Values are quoted as Spearman’s correlation coefficients with p values. Bold coefficients/p values are significant at p < 0.05
  2. ADMA asymmetric dimethylarginine, SDMA symmetric dimethylarginine, ACh acetylcholine, SNP sodium nitroprusside, FMD flow-mediated dilatation, GTN glyceryl-trinitrate-mediated dilatation, cIMT intima media thickness, SEVR subendocardial viability ratio, AIx augmentation index, HR heart rate